0001127602-20-004909.txt : 20200211 0001127602-20-004909.hdr.sgml : 20200211 20200211171503 ACCESSION NUMBER: 0001127602-20-004909 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200106 FILED AS OF DATE: 20200211 DATE AS OF CHANGE: 20200211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOSTER JAMES C CENTRAL INDEX KEY: 0001141722 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-15943 FILM NUMBER: 20598083 MAIL ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CENTRAL INDEX KEY: 0001100682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 061397316 FISCAL YEAR END: 1228 BUSINESS ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 BUSINESS PHONE: 781-222-6000 MAIL ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC DATE OF NAME CHANGE: 20000605 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19991208 4/A 1 form4a.xml PRIMARY DOCUMENT X0306 4/A 2020-01-06 2020-02-10 0001100682 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL 0001141722 FOSTER JAMES C 251 BALLARDVALE STREET WILMINGTON MA 01887 1 1 Chairman, President and CEO Common Stock 2020-01-06 5 G 0 E 3500 0 D 271015 D Common Stock 2020-02-07 4 A 0 73873 0 A 344888 D Common Stock 2020-02-07 4 F 0 31824 159.07 D 313064 D Common Stock 12800 I 2018 GRAT Common Stock 25000 I 2019 GRAT Common Stock 1500 I By Trust Common Stock 4500 I By Trust Common Stock 340 I By Trust Common Stock 10000 I Held By Spouse Reflects shares of common stock, issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 24,2017. Held by trust of which the reporting person is trustee. The reporting person disclaims beneficial ownership of these securities. Held by trust of which the reporting person is trustee. These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities. The original Form 4, filed on February 10, 2020, is being amended by this Form 4 amendment solely to correct an administrative error, which resulted in the omission of beneficial ownership of certain shares held by trust. /s/ Bobbie King as attorney-in-fact for James C. Foster 2020-02-11